Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Registrant is filing this Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2018 (“Amendment No. 1”) to correct an error on the cover page of the original Form 10-K as filed with the Securities and Exchange Commission on March 29, 2019 (the “Original Form 10-K”). The cover page of the Original Form 10-K incorrectly showed the total number of shares outstanding. The correct number of shares of the Registrant’s Common Stock outstanding as of March 28, 2019, was 21,490,610, as indicated on the cover page of this Amendment No. 1 (rather than 29,490,610 shares as originally shown, as the result of a typographical error).
No changes are hereby made to the Registrant’s financial statements. Other than the change discussed above and the filing of the currently dated Section 302 certifications and updated XBRL data under Item 15 of Part IV of this Amendment No. 1, no changes have been made to the Original Form 10-K or the exhibits filed therewith. As such, this Amendment No. 1 should be read in conjunction with the Original Form 10-K.
The information contained in this Amendment No. 1 does not reflect events occurring subsequent to the filing of the Original Form 10-K.
Any idea where these additional Brainstorm shares came from
As of March 28, 2019, the number of shares outstanding of the registrant's Common Stock, $0.00005 par value per share, was 29,490,610.
As of March 6, 2018, the number of shares outstanding of the registrant's Common Stock, $0.00005 par value per share, was 19,070,040.
Brainstorm ( BCLI )
http://contagiousforacure.com/
Contagious For A Cure
PLEASE ASK THE FDA TO APPROVE BRAINSTORM TODAY!!!
All the current movements in the ALS community have been driven from people suffering with the disease, families and loved ones.
We were behind “Right To Try” We have now met with the FDA.
All medicines that can change the course of our disease, have not been funded.
They still have 96 million in the bank.
576,000 have died since the ice bucket challenge.
Stand in the fight with us
Things are available that could help us today. PLEASE ASK THE FDA TO APPROVE BRAINSTORM TODAY!!!
http://contagiousforacure.com/
Contagious For A Cure
PLEASE ASK THE FDA TO APPROVE BRAINSTORM TODAY!!!
All the current movements in the ALS community have been driven from people suffering with the disease, families and loved ones.
We were behind “Right To Try” We have now met with the FDA.
All medicines that can change the course of our disease, have not been funded.
They still have 96 million in the bank.
576,000 have died since the ice bucket challenge.
Stand in the fight with us
Things are available that could help us today. PLEASE ASK THE FDA TO APPROVE BRAINSTORM TODAY!!!
Keep an eye on Brainstorm ( BCLI )
On February 22, 2019, Labaton Sucharow secured a major victory when the Delaware Supreme Court upheld the Court of Chancery’s decision to deny motions to dismiss a suit concerning Straight Path Communication’s $3.1 billion merger with Verizon. Labaton Sucharow, as co-lead counsel, represents Straight Path’s minority shareholders.
The action alleges that Straight Path’s controlling shareholder Howard Jonas breached his fiduciary duties in the sale, causing minority shareholders to lose at least hundreds of millions of dollars in value. Jonas controlled Straight Path and IDT Corporation, from which Straight Path was spun off in 2013.
In January 2017, Straight Path entered into a consent decree with the FCC regarding fraudulent conduct, which, among other things, forced Straight Path to sell itself to a third party and remit 20 percent of the sale proceeds as a fine to the FCC. Under an indemnification agreement between Straight Path and IDT, IDT was responsible for reimbursing Straight Path for that fine post-closing.
After an active bidding for Straight Path was underway, Jonas and his son, who he had previously installed as the CEO of Straight Path, hijacked the auction process, including by threatening individual board members and declaring that he would block any sale that preserved the indemnification claim. With no choice, the board released the claim against IDT for de minimis consideration.
On June 25, 2018, Vice Chancellor Glasscock of the Delaware Court of Chancery denied the defendants’ motion to dismiss, finding that the Jonases “directly harmed Straight Path’s other stockholders, who ended up receiving hundreds of millions of dollars less in merger consideration than they would have but for Howard’s dishonesty.”
Phoenix—Former U.S. Navy pilot Matt Bellina lives with amyotrophic lateral sclerosis (ALS), and since the time of his diagnosis in 2014, he had exhausted the treatment options available to him. But he successfully fought for the right to try investigational treatments so that he and others in his situation could have hope. Today, the Goldwater Institute is pleased to learn that Bellina is undergoing treatment for ALS under the federal Right to Try law. The treatment, NurOwn, is currently in Phase 3 trials.
In a Facebook post today, Bellina announced that he began the investigational treatment one month ago. Since his treatment began, he has experienced “increased core strength and coordination,” which now allows him to pull himself up to standing. Additionally, he has seen “subjective improvement” in his speech and swallowing. “I have been given a gift,” Bellina wrote of his treatment. “Because this is an investigational therapy we don’t know what tomorrow will bring but for now we are feeling incredibly blessed,” he continued.
https://goldwaterinstitute.org/article/former-navy-pilot-with-als-receives-treatment-under-federal-right-to-try-law/
Any thoughts on the purchase of 300,000 @ the open, of Brainstorm shares Friday ?
Or your thoughts on the purchase of 300,000 @ the open, of Brainstorm shares
Just asking if you had an opinion on the heavy interest in Fannie Mae
Interesting 300k BCLI purchase @ the open yesterday, are you watching the conversation on the Fannie Mae board ?
Any thoughts on this company BrainStorm Cell Therapeutics (NASDAQ:BCLI)
20 million share float, Phase 3 ALS Study
NurOwn® Phase III Trial in ALS
BrainStorm is proceeding with a randomized, double-blind, placebo-controlled multi-dose Phase 3 trial that is being conducted at multiple U.S. sites.
.NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of NurOwn® for the treatment of progressive multiple sclerosis (MS)
I would agree with that, 2019 and beyond could be very exciting for patients and investors
http://www.acc-holdings.com/index.php?lang=en
ACC International Holdings, through its Biotech subsidiary (ACCBT), is a controlling shareholder of Brainstorm Cell Therapeutics Inc (OTC.QB: BCLI), a leading developer of innovative, autologous adult stem cell therapies, for neurodegenerative diseases. BrainStorm's proprietary technology (NurOwn™) is in the late stages of development, and may use for treating severe and incurable disorders, such as Amyotrophic Lateral Sclerosis (ALS - also known in the US as Lou Gehrig's disease), Multiple Sclerosis (MS) Parkinson’s Disease (PD), and more.
BrainStorm is currently conducting a Phase IIa ALS clinical trial at the Hadassah University Medical Center in Jerusalem. The company is also scheduled to commence a Phase II clinical trial in the USA during 2013, pending FDA approval.
Given the fall in energy prices and pressure on real estate, I wonder how ACC International Holding is weathering the storm ???
http://www.acc-holdings.com/index.php?lang=en
Wonder what caused the late BCLI spike higher ???
I wonder if Artificial Intelligence will have any impact on there research in the future ???
Gaining more money without share dilution should aid the BCLI stock price, it seems like a lot of small cap biotech companies that are science rich but cash poor
Thank You, I started following AKTS because of your interest, when it comes to a number of these small companies, the compounding effect could be huge money makers if you get the sequence correct
Dr. Merit Cudkowicz opens the webinar with an overview of the various stem cell approaches currently being tested as potential treatments for ALS. Drs. Cudkowicz and Brown then discuss NurOwn, a Phase 3 stem cell trial for people with ALS. NurOwn is evaluating the safety and efficacy of repeated administration of NurOwn therapy, which is based on transplantation of autologous bone marrow derived mesenchymal stromal cells (MSC), which are enriched from the patient's own bone marrow, propagated ex vivo and induced to secrete Neurotrophic factors (NTFs).
https://vimeo.com/304232660?ref=tw-share
Fruit Compound Called Resveratrol May Strengthen Abilities of Stems Cells of ALS Patients
https://alsnewstoday.com/2018/12/04/resveratrol-fruit-compound-strenghtens-neuronal-abilities-of-als-derived-stem-cells-study-finds/?amp
Well perhaps a positive result for the Straight Path Shareholders in there lawsuit against IDT might aid Fibertower Stakeholders in some fashion.
Fibertower: Direct or Derivative ?????????????????????????????????????????
Stockholders of Straight Path Communications Inc. can press on with self-dealing claims against the company’s CEO and controlling stockholder that stem from its $3.1 billion sale to Verizon Communications Inc., a Delaware court decided.
Chancery Court Judge Sam Glasscock III, in a June 25 opinion, refused to dismiss allegations that former Straight Path controlling stockholder Howard Jonas and Straight Path CEO Davidi Jonas breached their fiduciary duties and siphoned potential benefits away from other shareholders.
Glasscock held that the claims of fiduciary duty breaches are direct, and not derivative as the defense argued. This allowed the lawsuit to survive. Stockholders lose their right to sue derivatively — against a third party on behalf of a company — once they cease to hold shares following a merger.
Remember, the Sealed Flynn Document could help a shareholder argument
I wonder what Codesilver thinks about your plan ???
Wonder what Levy and Faye are thinking now that AT&T can buy Time Warner
AT&T’s 5G Push To Power Tomorrow’s Smart Cities
https://www.pymnts.com/internet-of-things/2018/att-power-smart-cities-iot/
As a Predecessor in interest, could shareholders file suit against the FCC?
Levy Conclusion in Petition to Deny 4/13/2017
I respectfully ask AT&T not to be willfully blind in this matter and
consider making the effort to assist in rectifying this situation. AT&T
is asking the same hard working Americans to consume their products and services daily. We live in a new era of corporate morality and responsibility, one random onlooking outraged consumer’s hash tag could possibly put a dent in their brand worth significantly more than the minuscule efforts of placing the right phone to make sure the funds used to acquire FiberTower flow correctly to the victims harmed in this transaction.
If a Constructive fraud occured against th Fibertower Shareholders, would not the Wilful Blindness Doctrine apply to the 3 Parties involved, AT&T, The FCC, & The Reorganized Debtors. All 3 stand to benefit from the Settlement Agreement, however, do all 3 parties have the same level of legal protections for the actions taken within the Settlement Agreement ???
Posner Blowing Smoke, nobody in their right mind believes Solus sold every for 207 million
This was an entity that was engaged in fairly extensive proceedings, both administrative proceedings before the FCC, then appeals before the FCC, and appeals at the D.C. Circuit. When the prior debtholders converted their debt to equity and acquired the stock of the reorganized entity, they decided to shoulder the load on pursuing those avenues, with the hope that at some day they would either be successful or in some other way realize value on their investment.
And ultimately, they realized some value, because four years later after shouldering the load of pursuing those appeals and the expense of that, they -- there was a settlement reached with the FCC and a stock purchase agreement and they realized some value on their investment
Did Verizon and Straight Path have trouble explaining their transaction ?
MR. POSNER , to Mr. Fahy's point , I've read the settlement, although not this morning. I think it's -- you know, recognizing it's complicated stuff because it deals with things like spectrum and licenses and things -- I think it's pretty clear what was settled and reorganized
Have all the 24GHz licenses been returned to the FCC as per the Settlement Agreement ???
The behavior of AT&T does suggest they do have a concern with potential future risk. So if they were to provide a small pool of money for FTWR Shareholders, with the stipulation that if as a shareholder you receive compensation from this AT&T settlement, you are prevented from seeking additional funds from any future lawsuit, most folks would likely take the certain deal over the unknown at this time and date
Has the FCC announced the return of the Fibertower 24GHz licenses to the agency ?
Finding a billion dollar line on the balance sheet I think Trumps everything else
https://www.cnbc.com/2018/04/30/t-mobile-aborted-deal-for-straight-path-casts-light-on-sprint-merger.html
An obscure 2017 telecom deal explains why T-Mobile and Sprint agreed to merge
T-Mobile wanted to buy Straight Path last year, but it bowed out early after AT&T and Verizon bid up the company.
The insane bidding emphasized that Sprint and T-Mobile would have a difficult time competing with AT&T and Verizon on future spectrum auctions.
Concerns about 5G spending brought Sprint and T-Mobile together, although it's also a convenient rationale for a deal.
By now we’ve all heard that 5G is coming, and if you’re a mobile consumer you might be thinking, “so what?” Why should you care about the next generation of wireless network technology? Isn’t it just another iteration, bringing incremental changes that are no big deal?
No. No, it isn’t.
https://thenextweb.com/contributors/2018/04/28/time-get-excited-5g/